Document is current
Any future updates will be listed below
-
Authors
Zhao, Liming
Liu, Jiamei
Liu, Yin
Huang, Zhenna
Ye, Xuxiao
Lange, Jeff L.
Dhalwani, Nafeesa
Yang, Fan
Zhang, Zizhao
Chen, Kangyin
Zhang, Hao
Zhou, Jifang https://orcid.org/0000-0003-2590-8667
-
Funding
Funding for this research was provided by:
Amgen
- License Information
-
More Information
Article History
Received: 24 February 2025
Accepted: 4 April 2025
First Online: 25 April 2025
Declarations
:
: Zhenna Huang, Xuxiao Ye, Jeff L. Lange, Nafeesa Dhalwani are Amgen employees. Zhenna Huang, Jeff L. Lange, Nafeesa Dhalwani are Amgen stockholders. All other authors (Liming Zhao, Jiamei Liu, Yin Liu, Fan Yang, Zizhao Zhang, Kangyin Chen, Hao Zhang and Jifang Zhou) declare no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. All listed authors meet the authorship requirements as detailed in the ICMJE guidelines.
: The study protocol was approved by the Institutional Review Board of The Second Hospital of Tianjin Medical University and China Pharmaceutical University (2024-09-137). This study was performed in accordance with the Helsinki Declaration of 1964. Patient informed consent was waived as the data source was anonymized. All authors have approved the publication of this study. Data from TRHD can only be analyzed on the secured site by qualified investigators and the principal investigator’s team had permission to access the database from database owner.
